How can we help you?
The latest from MDFA
Don’t defer essential eye appointments during lockdown
Macular Disease Foundation Australia (MDFA) is seeking to clear up any confusion around deferring eye appointments during lockdown.
A research update on early detection of macular disease: webinar
In this webinar, Early Detection of Macular Disease: A Research Update, you’ll learn about current research into improving detection of macular disease.
James Muecke MDFA ambassador
Macular Disease Foundation Australia is delighted to officially welcome Dr James Muecke AM on board as MDFA’s diabetic eye disease Ambassador.
COVID-19 update
With Governments around Australia rolling out vaccines for COVID-19, a frequent question to our National Helpline is about safety of the vaccine when receiving eye injections.
Support life-changing research
Your donations make MDFA the largest non-government source of macular disease research funding in Australia. Donate to our tax appeal to help support life-changing research.
Macular Disease Foundation Australia awards $1 million to eight exciting research projects
Macular Disease Foundation Australia (MDFA) has awarded more than $1 million in research funding to eight promising projects, in a ceremony marking 10 years of significant advances in the search for a cure to Australia’s leading cause of blindness.
Inaugural Ita Buttrose Oration
MDFA Patron Ita Buttrose AC OBE calls on Government to reject Medicare eye injection rebate cut.
Macula Month
May is Macula Month, our annual awareness campaign to help Australians understand their risk of macular diseases and take early action to save their sight.
Ita Buttrose Oration
Ita will be the keynote speaker at this inaugural oration. She will address the big issues relating to eye health and vulnerable older Australians who are at risk of blindness.
Macular disease is the leading cause of blindness and severe vision loss in Australia. Early action saves sight. Find out about age-related macular degeneration, diabetic eye disease and other macular conditions.
Learn More
